StockData
Artiva Biotherapeutics, Inc. logo

Artiva Biotherapeutics, Inc. (ARTV) stock

ARTVNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$3.86−0.10 (-2.53%)

Close on Nov 17, 2026Market cap $188.72MP/E –Yield –

Artiva Biotherapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Artiva Biotherapeutics's price to book ratio was 0.3× on Nov 11, 2026, against 0.3× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.3×+0.2
2025Jan 31, 20250.1×−0.1
2024Dec 31, 20240.3×–

More Artiva Biotherapeutics figures

See a number that looks wrong?